Opioid-based micro and nanoparticulate formulations: alternative approach on pain management

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Microencapsulation

• Publication date

  2016-01-02

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.3109/02652048.2015.1134687PMID 26786722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Encapsulation of Drugs Within Liposomes by pH-Gradient Techniques

  2016cited by this paper
• Opioid receptor desensitization: mechanisms and its link to tolerance

  2014cited by this paper
• Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

  2014cited by this paper
• Prevalence of chronic pain and related risk factors in military veterans: a systematic review protocol

  2014cited by this paper
• Externally addressable hydrogel nanocomposites for biomedical applications

  2014cited by this paper
• A comparison of chronic pain prevalence in Japan, Thailand, and myanmar.

  2013influential reference
• Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier

  2013cited by this paper
• Differential Uptake of Nanoparticles and Microparticles by Pulmonary APC Subsets Induces Discrete Immunological Imprints

  2013cited by this paper
• Advances in Brain Targeted Drug Delivery: Nanoparticulate Systems

  2013cited by this paper
• Design of an Interpolyelectrolyte Gastroretentive Matrix for the Site-Specific Zero-Order Delivery of Levodopa in Parkinson’s Disease

  2013cited by this paper
• Liposomal drug delivery systems: from concept to clinical applications.

  2013cited by this paper
• Advanced materials and processing for drug delivery: the past and the future.

  2013cited by this paper
• Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application.

  2013cited by this paper
• Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery

  2013cited by this paper
• Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse.

  2013cited by this paper
• Chronic pain epidemiology and its clinical relevance.

  2013cited by this paper
• [Prevalence of chronic pain in Germany. A representative survey of the general population].

  2013cited by this paper
• Prävalenz chronischer Schmerzen in Deutschland

  2013influential reference
• Nanoparticles as Blood-Brain Barrier Permeable CNS Targeted Drug Delivery Systems

  2013cited by this paper
• Preparation, characterization and in vitro release properties of morphine-loaded PLLA-PEG-PLLA microparticles via solution enhanced dispersion by supercritical fluids

  2013influential reference
• Particles and powders: tools of innovation for non-invasive drug administration.

  2012cited by this paper
• Preparation of water soluble drugs-loaded microparticles using modified solution enhanced dispersion by supercritical CO2

  2012cited by this paper
• Prevalence of chronic pain, insomnia, and fatigue in Hong Kong.

  2012cited by this paper
• Transport of drugs across the blood-brain barrier by nanoparticles.

  2012cited by this paper
• Functional coating of liposomes using a folate– polymer conjugate to target folate receptors

  2012cited by this paper
• Models for oral uptake of nanoparticles in consumer products

  2012cited by this paper
• PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.

  2012cited by this paper
• The economic costs of pain in the United States.

  2012cited by this paper
• Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery

  2011cited by this paper
• EFFECT OF POLYMERIC BLEND ON THE DISSOLUTION BEHAVIOR OF SPRAY-DRIED MICROPARTICLES

  2011cited by this paper
• Development and in vitro-in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride.

  2011cited by this paper
• Formulation of solid lipid nanoparticles and their applications.

  2011cited by this paper
• The prevalence of chronic pain in Canada.

  2011influential reference
• Critical factors in the release of drugs from sustained release hydrophilic matrices.

  2011cited by this paper
• Drug transport to brain with targeted nanoparticles

  2011cited by this paper
• Comparison of extended-release epidural morphine with femoral nerve block to patient-controlled epidural analgesia for postoperative pain control of total knee arthroplasty: a case-controlled study.

  2011cited by this paper
• How neuroimaging studies have challenged us to rethink: is chronic pain a disease?

  2010cited by this paper
• 3D-wound healing model: influence of morphine and solid lipid nanoparticles.

  2010cited by this paper
• The burden of neuropathic pain: A systematic review and meta‐analysis of health utilities

  2010cited by this paper
• Hot tabletting of slow-release tramadol hydrochloride microcapsules with cores obtained via compaction

  2010cited by this paper
• Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles.

  2010cited by this paper
• Continuous epidural infusion of morphine versus single epidural injection of extended-release morphine for postoperative pain control after arthroplasty: a retrospective analysis

  2010cited by this paper
• Chitosan-Genipin Microspheres for the Controlled Release of Drugs: Clarithromycin, Tramadol and Heparin

  2010cited by this paper
• Development of oral suspensions of microparticles of ethylcellulose with tramadol

  2010cited by this paper
• Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.

  2010cited by this paper
• Solid Lipid Nanoparticles as Drug Delivery System

  2010cited by this paper
• Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems.

  2010cited by this paper
• Challenges of medication management in hospitalized patients with Parkinson's disease.

  2010cited by this paper
• The prevalence of chronic pain in United States adults: results of an Internet-based survey.

  2010influential reference
• Opioids in chronic noncancer pain

  2010cited by this paper
• Preparation and in vivo evaluation of thienorphine-loaded PLGA microspheres.

  2010cited by this paper
• Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.

  2010cited by this paper
• Non-destructive methods of characterization of risperidone solid lipid nanoparticles.

  2010influential reference
• Pharmacokinetics and Behavioral Effects of an Extended-Release, Liposome-Encapsulated Preparation of Oxymorphone in Rhesus Macaques

  2009influential reference
• Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

  2009cited by this paper
• Dry powder nasal vaccines as an alternative to needle-based delivery.

  2009cited by this paper
• Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles

  2009cited by this paper
• Characterization of the three major polymorphic forms and liquid state of tristearin by Raman spectroscopy.

  2009cited by this paper
• Kollidon SR colloidal particles as vehicles for oral morphine delivery in pain treatment.

  2009cited by this paper
• Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles.

  2009cited by this paper
• Lipid nanoparticles for parenteral delivery of actives.

  2009cited by this paper
• Development of Tramadol Microparticles by Non-solvent Addition Method and their In Vitro Characterization

  2009cited by this paper
• Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.

  2009cited by this paper
• Curvature effects on lipid packing and dynamics in liposomes revealed by coarse grained molecular dynamics simulations.

  2009cited by this paper
• How neuroimaging studies have challenged us to rethink: is chronic pain a disease?

  2009cited by this paper
• Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.

  2009cited by this paper
• Opioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective

  2008cited by this paper
• Protein and Peptide Drug Delivery: Oral Approaches

  2008cited by this paper
• Efficacy of Opioids for Chronic Pain: A Review of the Evidence

  2008cited by this paper
• In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus.

  2008cited by this paper
• Sub-micron and nanoscale feature depth modulates alignment of stromal fibroblasts and corneal epithelial cells in serum-rich and serum-free media.

  2008cited by this paper
• Comparison and validation of drug loading parameters of PEGylated nanoparticles purified by a diafiltration centrifugal device and tangential flow filtration.

  2008cited by this paper
• Effectiveness of opioids in the treatment of chronic non-cancer pain.

  2008cited by this paper
• Opioid pharmacology.

  2008cited by this paper
• Effects of intrathecal solid lipid nanoparticles morphine on acute nociception in rats

  2008cited by this paper
• Comparison and Validation of Drug Loading Parameters of PEGylated Nanoparticles Purified by a Diafiltration Centrifugal Device and Tangential Flow Filtration

  2008cited by this paper
• Chemical characterization with XPS of the surface of polymer microparticles loaded with morphine.

  2007cited by this paper
• Microparticles and nanoparticles for drug delivery.

  2007cited by this paper
• Nanoparticles - A Review

  2007cited by this paper
• Opiates and opioids: what a difference a name makes.

  2007cited by this paper
• DepoDur® (extended-release epidural morphine): a review of an old drug in a new vehicle

  2007cited by this paper
• Extended-duration agents for perioperative pain management

  2007cited by this paper
• Effectiveness of polymer-coated extended-release morphine sulfate capsules in older patients with persistent moderate-to-severe pain: A subgroup analysis of a large, open-label, community-based trial.

  2007cited by this paper
• Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles

  2007cited by this paper
• Incoherent quasielastic neutron scattering study on the polymorphism of tristearin: dynamical properties of hydrocarbon chains.

  2007cited by this paper
• (820): Once-a-day AVINZA vs. twice daily OxyContin® in an open-label extension (part II) to the ACTION trial for the treatment of chronic moderate-to-severe low back pain

  2006cited by this paper
• Primary microparticles and agglomerates of morphine for nasal insufflation.

  2006cited by this paper
• Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.

  2006cited by this paper
• The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates.

  2006cited by this paper
• (825): Pain control in chronic non-cancer pain patients treated with once-a-day AVINZA (morphine sulfate extended-release capsules)

  2006cited by this paper
• 総論;総論;Introduction

  2006cited by this paper
• Liposomes: an overview of manufacturing techniques.

  2005cited by this paper
• Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique

  2005cited by this paper
• The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

  2005cited by this paper
• Extended-release epidural morphine (DepoDur).

  2005cited by this paper
• High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic/pharmacodynamic studies in rats.

  2005cited by this paper
• A Comparison of Depodur™, a Novel, Single-Dose Extended-Release Epidural Morphine, with Standard Epidural Morphine for Pain Relief After Lower Abdominal Surgery

  2005cited by this paper
• Synthesis, properties, and applications of iron nanoparticles.

  2005cited by this paper
• In vitro evaluation of a morphine polymeric complex: Flowability behavior and dissolution study

  2004cited by this paper
• Comparative study of morphine diffusion from sustained release polymeric suspensions.

  2004cited by this paper

• Continuous preparation of long-acting hydromorphone PLGA microspheres using an automatic and scalable microfluidic process system.

  2025cites this paper
• Natural drug delivery systems for the treatment of neurodegenerative diseases

  2025cites this paper
• Diclofenac sodium nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the spinal cord of SNI rats.

  2024cites this paper
• Recent advances in pain management based on nanoparticle technologies

  2022cites this paper
• Nanotechnology for Pain Management: Current and Future Therapeutic Interventions.

  2021cites this paper
• Emerging role of nanomedicine in the treatment of neuropathic pain

  2019cites this paper
• Determination of mechanical properties of polymeric microspheres used in controlled drug delivery systems by nanoindentation

  2018cites this paper
• Application of 1-Dimensional and 2-Dimensional Solid-State Nuclear Magnetic Resonance Spectroscopy to the Characterization of Morphine, Morphine Hydrochloride, and Their Hydrates.

  2017cites this paper
• Development of functionalized hollow microporous organic capsules encapsulating morphine - an in vitro and in vivo study.

  2017cites this paper
• p,p'-Methoxyl-diphenyl diselenideincorporation into polymeric nanocapsules improves its antinociceptive action: Physicochemical and behavioral studies.

  2017cites this paper
• Sleep, chronic pain, and opioid risk for apnea

  2017cites this paper